Treatment of NZB/W mice with anti-IFN-γ or deletion of the IFN-γ receptor resulted in prolonged survival, diminished frequency and delayed onset of proteinuria, decreased autoAb levels, and decreased histopathologic evidence of glomerulonephritis [37-39]. The gene discussed is IFNG; the disease is glomerulonephritis.